← Back to headlines
GeneDx Reports Strong Q4 Earnings and Reaffirms 2026 Revenue Guidance
GeneDx saw its stock rise following a strong performance in the fourth quarter, exceeding expectations. The company also reiterated its revenue guidance for 2026, signaling confidence in its future financial outlook.
23 Feb, 18:01 — 23 Feb, 18:01
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Lode Gold Resources to Exhibit at PDAC 2026 Conference in Toronto
just now
Bitcoin ETFs are hemorrhaging billions. Here’s what investors awaiting a crypto turnaround should watch for.
just now
Wall Street dragged down by AI-disruption fears, tariff uncertainty
just now
LatAM FX up, stocks mixed as US trade uncertainty looms; Mexican assets slide - TradingView
just now